About TCGA
TCGA offers products and services including Genotyping Services and Proteomics.
- SectorsHealthcare
- Legal Name The Center Genomic Application, Inc
Products & Services of TCGA
TCGA offers a comprehensive portfolio of products and services, including Genotyping Services and Proteomics.
Genotyping by Massarray technology is performed to support research in biomolecular interactions.
Proteomics is offered to analyze intricate biomolecular interactions in therapeutic development.
Web traffic of TCGA
Websites that share an audience with TCGA (tcgaresearch.org).
Websites whose visitors overlap most with TCGA. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ocimumbio.com | 100% | – | – | View details |
Similar companies to TCGA
10 companies that operate in the same segment as TCGA (Clinical Genomics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Panomic profiling technologies are developed for cancer precision medicine. | 1996 | Irving, Texas, United States | USD 1.23 B | – | 1,339 | |
Genomics-based diagnostic tests for cancer are provided. | 2010 | Cambridge, Massachusetts, United States | USD 96.5 M | – | – | |
Digital molecular biology analytics are developed for disease management. | 2012 | Carlsbad, California, United States | USD 95.02 M | – | 46 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Genomic database for clinical research is provided. | 2015 | San Francisco, California, United States | USD 435 M | – | – | |
Genomic sequencing and diagnosis software is provided for healthcare. | 2011 | Menlo Park, California, United States | USD 87.3 M | USD 69.65 M | 229 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TCGA
TCGA is identified as a provider of genomic applications, including genotyping by Massarray technology and oligo nucleotide synthesis, alongside proteomics and NAT services. Glycoproteomics is emphasized for its role in therapeutic advancement, where it bridges laboratory analysis and clinical applications by exploring glycosylations effects on protein functionality and drug development. Glycan-protein interactions are utilized to foster innovations in modern medicine, such as glycan-based treatments and monoclonal antibody efficacy, highlighting contributions to biotechnology progress.
TCGA offers Genotyping Services and Proteomics.
TCGA operates through The Center Genomic Application, Inc.